1-172551580-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014283.5(SUCO):c.131A>G(p.Asp44Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000426 in 1,610,958 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014283.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUCO | NM_014283.5 | c.131A>G | p.Asp44Gly | missense_variant | 2/24 | ENST00000263688.4 | NP_055098.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUCO | ENST00000263688.4 | c.131A>G | p.Asp44Gly | missense_variant | 2/24 | 1 | NM_014283.5 | ENSP00000263688.3 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000431 AC: 107AN: 248344Hom.: 0 AF XY: 0.000491 AC XY: 66AN XY: 134322
GnomAD4 exome AF: 0.000422 AC: 616AN: 1458856Hom.: 2 Cov.: 29 AF XY: 0.000453 AC XY: 329AN XY: 725704
GnomAD4 genome AF: 0.000467 AC: 71AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000511 AC XY: 38AN XY: 74300
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 44 of the SUCO protein (p.Asp44Gly). This variant is present in population databases (rs145307638, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SUCO-related conditions. ClinVar contains an entry for this variant (Variation ID: 1358511). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | SUCO: BP4 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | The c.131A>G (p.D44G) alteration is located in exon 2 (coding exon 2) of the SUCO gene. This alteration results from a A to G substitution at nucleotide position 131, causing the aspartic acid (D) at amino acid position 44 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at